Post-transplant lymphoproliferative disorder: a review
AW Loren, DL Porter, EA Stadtmauer… - Bone marrow …, 2003 - nature.com
Post-transplant lymphoproliferative disorder (PTLD) represents a spectrum of Epstein–Barr
virus-related (EBV) clinical diseases, from a benign mononucleosis-like illness to a fulminant …
virus-related (EBV) clinical diseases, from a benign mononucleosis-like illness to a fulminant …
Medical management update: Non-Hodgkin lymphoma
H Mawardi, C Cutler, N Treister - Oral Surgery, Oral Medicine, Oral …, 2009 - Elsevier
Lymphoma is a heterogeneous malignancy of the lymphatic system characterized by
proliferation of lymphoid cells or their precursors. Non-Hodgkin lymphoma (NHL) is …
proliferation of lymphoid cells or their precursors. Non-Hodgkin lymphoma (NHL) is …
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
O Landgren, ES Gilbert, JD Rizzo… - Blood, The Journal …, 2009 - ashpublications.org
We evaluated 26 901 patients who underwent allogeneic hematopoietic cell transplantation
(HCT) at 271 centers worldwide to define patterns of posttransplantation lymphoproliferative …
(HCT) at 271 centers worldwide to define patterns of posttransplantation lymphoproliferative …
Prevention of Epstein-Barr virus–lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell …
JWJ van Esser, HGM Niesters… - Blood, The Journal …, 2002 - ashpublications.org
Recipients of a partially T-cell–depleted (TCD) allogeneic stem cell transplantation (allo-
SCT) developing reactivation of Epstein-Barr virus (EBV) with quantified viral DNA levels …
SCT) developing reactivation of Epstein-Barr virus (EBV) with quantified viral DNA levels …
Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease …
JWJ van Esser, B van der Holt, E Meijer… - Blood, The Journal …, 2001 - ashpublications.org
Reactivation of the Epstein-Barr virus (EBV) after allogeneic stem cell transplantation (allo-
SCT) may evoke a protective cellular immune response or may be complicated by the …
SCT) may evoke a protective cellular immune response or may be complicated by the …
Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated …
Umbilical cord blood (UCB) is increasingly used as an alternative source of hematopoietic
stem cells for transplantation for patients who lack a suitable sibling donor. Despite concerns …
stem cells for transplantation for patients who lack a suitable sibling donor. Despite concerns …
Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients
P Hiwarkar, HB Gaspar, K Gilmour, M Jagani… - Bone marrow …, 2013 - nature.com
While pre-emptive rituximab therapy for EBV has substantially reduced the incidence of post-
transplant lymphoproliferative disorder, following allogeneic haematopoietic SCT (HSCT) …
transplant lymphoproliferative disorder, following allogeneic haematopoietic SCT (HSCT) …
Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses
H Karlsson, S Samarasinghe, LM Ball… - Blood, The Journal …, 2008 - ashpublications.org
Mesenchymal stem cells (MSCs) suppress alloantigen-induced T-cell functions in vitro and
infusion of third-party MSCs seems to be a promising therapy for graft-versus-host disease …
infusion of third-party MSCs seems to be a promising therapy for graft-versus-host disease …
Impaired recovery of Epstein-Barr virus (EBV)—specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at …
P Meij, JWJ van Esser, HGM Niesters, D van Baarle… - Blood, 2003 - ashpublications.org
Abstract Epstein-Barr virus (EBV)—specific cytotoxic T lymphocytes are considered pivotal to
prevent lymphoproliferative disease (LPD) in allogeneic stem cell transplantation (SCT) …
prevent lymphoproliferative disease (LPD) in allogeneic stem cell transplantation (SCT) …
[HTML][HTML] Risk factors for and the clinical impact of cytomegalovirus and Epstein-Barr virus infections in pediatric recipients of TCR-α/β–and CD19-depleted grafts
A Laberko, A Bogoyavlenskaya, L Shelikhova… - Biology of Blood and …, 2017 - Elsevier
Alpha/beta T cell and CD19 depletion are used to improve the outcomes of hematopoietic
stem cell transplantation (HSCT). We evaluated the burden of cytomegalovirus (CMV) and …
stem cell transplantation (HSCT). We evaluated the burden of cytomegalovirus (CMV) and …